355 related articles for article (PubMed ID: 24696735)
21. ALK-negative CNS anaplastic large cell lymphoma: case report and review of literature.
Lannon M; Lu JQ; Chum M; Wang BH
Br J Neurosurg; 2023 Oct; 37(5):1245-1250. PubMed ID: 33253051
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.
Merkel O; Hamacher F; Griessl R; Grabner L; Schiefer AI; Prutsch N; Baer C; Egger G; Schlederer M; Krenn PW; Hartmann TN; Simonitsch-Klupp I; Plass C; Staber PB; Moriggl R; Turner SD; Greil R; Kenner L
J Pathol; 2015 Aug; 236(4):445-56. PubMed ID: 25820993
[TBL] [Abstract][Full Text] [Related]
23. Anaplastic large cell lymphoma, ALK-positive.
Ferreri AJ; Govi S; Pileri SA; Savage KJ
Crit Rev Oncol Hematol; 2012 Aug; 83(2):293-302. PubMed ID: 22440390
[TBL] [Abstract][Full Text] [Related]
24. How to Diagnose Anaplastic Large Cell Lymphoma on Cytological Samples? A Series with Emphasis on Diagnostic Clue and Pitfalls.
Montella M; Lucà S; Ronchi A; Marino FZ; Caputo A; Sica A; Zeppa P; Franco R; Cozzolino I
Acta Cytol; 2023; 67(3):230-239. PubMed ID: 36634640
[TBL] [Abstract][Full Text] [Related]
25. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
[TBL] [Abstract][Full Text] [Related]
26. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.
Eyre TA; Khan D; Hall GW; Collins GP
Eur J Haematol; 2014 Dec; 93(6):455-68. PubMed ID: 24766435
[TBL] [Abstract][Full Text] [Related]
27. Primary Gastric ALK-negative EBV-negative Anaplastic Large Cell Lymphoma Presenting with Iron Deficiency Anemia.
Zhang W; Burton S; Wu S; Qian X; Rajeh MN; Schroeder K; Shuldberg M; Merando A; Lai JP
In Vivo; 2017; 31(4):701-704. PubMed ID: 28652442
[TBL] [Abstract][Full Text] [Related]
28. [Anaplastic lymphoma kinase gene abnormality and the expression of its fusion protein in primary systemic anaplastic large cell lymphoma].
Shi YF; Liu CL; Zhou CJ; Gong LP; Dong LN; Li M; Huang X; Gao ZF
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):380-6. PubMed ID: 18677384
[TBL] [Abstract][Full Text] [Related]
29. A Case of ALK+ Anaplastic Large-Cell Lymphoma With Aberrant Myeloperoxidase Expression and Initial Cutaneous Presentation.
Gru AA; Voorhess PJ
Am J Dermatopathol; 2018 Jul; 40(7):519-522. PubMed ID: 29905579
[TBL] [Abstract][Full Text] [Related]
30. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.
Drexler HG; Gignac SM; von Wasielewski R; Werner M; Dirks WG
Leukemia; 2000 Sep; 14(9):1533-59. PubMed ID: 10994999
[TBL] [Abstract][Full Text] [Related]
31. Primary ALK-1-negative anaplastic large cell lymphoma of the brain: case report and review of the literature.
Kodama K; Hokama M; Kawaguchi K; Tanaka Y; Hongo K
Neuropathology; 2009 Apr; 29(2):166-71. PubMed ID: 18564100
[TBL] [Abstract][Full Text] [Related]
32. High-dose methotrexate monotherapy followed by radiation for CD30-positive, anaplastic lymphoma kinase-1-positive anaplastic large-cell lymphoma in the brain of a child.
Furuya K; Takanashi S; Ogawa A; Takahashi Y; Nakagomi T
J Neurosurg Pediatr; 2014 Sep; 14(3):311-5. PubMed ID: 25014324
[TBL] [Abstract][Full Text] [Related]
33. The t(2;5) in human lymphomas.
Kadin ME; Morris SW
Leuk Lymphoma; 1998 Apr; 29(3-4):249-56. PubMed ID: 9684923
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes.
Boi M; Todaro M; Vurchio V; Yang SN; Moon J; Kwee I; Rinaldi A; Pan H; Crescenzo R; Cheng M; Cerchietti L; Elemento O; Riveiro ME; Cvitkovic E; Bertoni F; Inghirami G;
Oncotarget; 2016 Nov; 7(48):79637-79653. PubMed ID: 27793034
[TBL] [Abstract][Full Text] [Related]
35. Primary central nervous system ALK positive anaplastic large cell lymphoma with predominantly leptomeningeal involvement in an adult.
Park JS; Park H; Park S; Kim SJ; Seol HJ; Ko YH
Yonsei Med J; 2013 May; 54(3):791-6. PubMed ID: 23549832
[TBL] [Abstract][Full Text] [Related]
36. Aberrant expression and genetic alteration of c-MYC in anaplastic large cell lymphoma.
Chen Z; Chai F; Xi Y; Zhang H; Xu Y; Zhang Z; Li S; Tian X
J Cancer Res Clin Oncol; 2022 Jan; 148(1):267-278. PubMed ID: 34131801
[TBL] [Abstract][Full Text] [Related]
37. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
[TBL] [Abstract][Full Text] [Related]
38. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.
Shin HJ; Thorson P; Gu J; Katz RL
Diagn Cytopathol; 2003 Aug; 29(2):61-6. PubMed ID: 12889041
[TBL] [Abstract][Full Text] [Related]
39. EMMPRIN (CD147) is induced by C/EBPβ and is differentially expressed in ALK+ and ALK- anaplastic large-cell lymphoma.
Schmidt J; Bonzheim I; Steinhilber J; Montes-Mojarro IA; Ortiz-Hidalgo C; Klapper W; Fend F; Quintanilla-Martínez L
Lab Invest; 2017 Sep; 97(9):1095-1102. PubMed ID: 28581487
[TBL] [Abstract][Full Text] [Related]
40. ALK expression plays different roles in anaplastic large-cell lymphomas and outcome of crizotinib use in relapsed/refractory ALK+ patients in a Chinese population.
Huang L; Zhang F; Zeng J; Guo H; Liu S; Wei X; Chen F; Jiang X; Liang Z; Liu Y; Li W
Ann Hematol; 2018 Jan; 97(1):149-159. PubMed ID: 29150811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]